MSD Partners
PLXP

MSD Partners’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

MSD Partners’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,303,800
Closed -$847K – 82
2022
Q3 		$847K Sell
1,303,800
-571,200
-30% -$842K 0.07% 51
2022
Q2 		$4.56M Hold
1,875,000
– – 0.28% 23
2022
Q1 		$7.58M Sell
1,875,000
-3,750,000
-67% -$20.6M 0.41% 17
2021
Q4 		$45.1M Buy
5,625,000
+3,750,000
+200% +$44M 0.49% 20
2021
Q3 		$36.2M Hold
1,875,000
– – 1.1% 17
2021
Q2 		$25.9M Hold
1,875,000
– – 0.68% 20
2021
Q1 		$16.9M Buy
+1,875,000
New +$13.7M 0.64% 28

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Steel Grove Capital Advisors
Steel Grove Capital Advisors Memphis, Tennessee $1.12B AUM 20.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

MSD Partners's PLXP Position: Q4 2022 in Review

MSD Partners sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 1,303,800 shares — an estimated $847K sold.

MSD Partners first reported a position in PLXP in Q1 2021 and held it in 7 quarters. The position peaked at $45.1M in Q4 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • MSD Partners reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • MSD Partners sold 1,303,800 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $847K.
  • MSD Partners first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • MSD Partners's PLx Pharma Inc. Common Stock position peaked at $45.1M in Q4 2021.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on MSD Partners's 13F filing for Q4 2022, filed 14 Feb 2023.